Skip to main content
. Author manuscript; available in PMC: 2020 May 15.
Published in final edited form as: Clin Cancer Res. 2019 Feb 8;25(10):3141–3151. doi: 10.1158/1078-0432.CCR-18-2953

Figure 1. Cancer genome alterations in 58 thyroid cancer cell lines.

Figure 1.

Cell line names, normal tissue availability (paired normal or pooled control), patient’s age, gender, original tumor type and derivation are shown in the top panel. Genes are listed on the left of the oncoprint, and the percentage of samples harboring genetic alterations in those genes is shown on the right. Genes are clustered in functional groups, where indicated. The number of variants identified in each cell line is shown in the bottom-most panel. Color codes for mutational and clinicopathological features are listed in the boxes on the right.